| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
25,251 |
22,805 |
$1.74M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
30,569 |
28,045 |
$1.54M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,733 |
4,192 |
$379K |
| 71046 |
Radiologic examination, chest; 2 views |
5,421 |
4,979 |
$270K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,597 |
2,371 |
$261K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
40,112 |
35,110 |
$222K |
| 80053 |
Comprehensive metabolic panel |
28,828 |
24,986 |
$205K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,844 |
2,680 |
$191K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,319 |
1,170 |
$169K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,953 |
3,718 |
$167K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,690 |
5,998 |
$154K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
473 |
421 |
$151K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,188 |
2,929 |
$106K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,765 |
3,678 |
$98K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,915 |
2,668 |
$95K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,045 |
5,544 |
$74K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,989 |
4,506 |
$71K |
| 36415 |
Collection of venous blood by venipuncture |
26,784 |
23,695 |
$67K |
| G0378 |
Hospital observation service, per hour |
481 |
372 |
$53K |
| 71045 |
Radiologic examination, chest; single view |
2,125 |
1,878 |
$50K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,091 |
907 |
$48K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,434 |
5,855 |
$45K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
97 |
87 |
$36K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,893 |
2,112 |
$33K |
| 84484 |
|
4,597 |
3,728 |
$29K |
| 81025 |
|
5,125 |
4,572 |
$28K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,346 |
1,276 |
$28K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
364 |
348 |
$28K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,305 |
1,200 |
$28K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,247 |
1,510 |
$26K |
| 59025 |
Fetal non-stress test |
771 |
588 |
$25K |
| 86850 |
|
2,430 |
2,222 |
$25K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
383 |
358 |
$25K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,581 |
1,503 |
$23K |
| 83655 |
|
1,837 |
1,737 |
$22K |
| 80061 |
Lipid panel |
1,903 |
1,760 |
$21K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,652 |
1,503 |
$21K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
645 |
621 |
$19K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,735 |
2,480 |
$19K |
| 86710 |
|
1,524 |
1,377 |
$19K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
589 |
544 |
$19K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
642 |
595 |
$18K |
| 81001 |
|
8,234 |
7,465 |
$18K |
| 86803 |
|
1,338 |
1,235 |
$17K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
9,033 |
7,928 |
$17K |
| 83970 |
|
784 |
735 |
$16K |
| 87340 |
|
1,631 |
1,522 |
$16K |
| 86593 |
|
3,870 |
3,577 |
$16K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
133 |
85 |
$16K |
| 84439 |
|
1,800 |
1,622 |
$15K |
| 83690 |
|
2,827 |
2,559 |
$14K |
| 76830 |
Ultrasound, transvaginal |
273 |
211 |
$14K |
| 80069 |
|
2,351 |
2,162 |
$13K |
| 80050 |
General health panel |
320 |
298 |
$13K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
322 |
310 |
$12K |
| 81003 |
|
7,467 |
6,677 |
$12K |
| 87081 |
|
1,880 |
1,636 |
$11K |
| 83001 |
|
632 |
589 |
$11K |
| 84146 |
|
548 |
488 |
$10K |
| C9399 |
Unclassified drugs or biologicals |
10,175 |
6,910 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
265 |
210 |
$9K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
372 |
310 |
$9K |
| 86762 |
|
636 |
591 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
572 |
431 |
$8K |
| 83880 |
|
431 |
395 |
$8K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
109 |
83 |
$7K |
| 83735 |
|
1,799 |
1,540 |
$6K |
| 82951 |
|
560 |
475 |
$6K |
| 86140 |
|
1,639 |
1,508 |
$6K |
| 84702 |
|
468 |
369 |
$6K |
| 83020 |
|
458 |
438 |
$6K |
| 85379 |
|
975 |
891 |
$6K |
| 83605 |
|
885 |
738 |
$5K |
| 82043 |
|
1,531 |
1,426 |
$5K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
863 |
182 |
$5K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,677 |
3,136 |
$5K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,596 |
1,266 |
$5K |
| 86787 |
|
410 |
366 |
$5K |
| 87070 |
|
516 |
500 |
$5K |
| 86703 |
|
434 |
416 |
$5K |
| 82652 |
|
512 |
433 |
$5K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
67 |
57 |
$4K |
| 82570 |
|
1,190 |
1,112 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
762 |
654 |
$4K |
| 0011A |
|
295 |
137 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,522 |
1,367 |
$4K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
61 |
53 |
$4K |
| 84144 |
|
191 |
167 |
$3K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
12 |
12 |
$3K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
593 |
526 |
$3K |
| 0012A |
|
184 |
127 |
$3K |
| 82947 |
|
667 |
624 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
16 |
14 |
$3K |
| 83002 |
|
146 |
140 |
$3K |
| 82105 |
|
134 |
130 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
632 |
528 |
$2K |
| 84156 |
|
740 |
653 |
$2K |
| 87040 |
|
378 |
227 |
$2K |
| 86696 |
|
116 |
104 |
$2K |
| 76801 |
|
26 |
26 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
12 |
12 |
$2K |
| 83721 |
|
306 |
229 |
$2K |
| 86901 |
|
549 |
483 |
$2K |
| 87807 |
|
92 |
89 |
$1K |
| 0001A |
|
36 |
35 |
$1K |
| 0002A |
|
37 |
34 |
$1K |
| 80178 |
|
274 |
253 |
$1K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
294 |
251 |
$1K |
| 82607 |
|
93 |
88 |
$1K |
| 82746 |
|
92 |
87 |
$1K |
| 73630 |
|
32 |
25 |
$1K |
| G0379 |
Direct admission of patient for hospital observation care |
20 |
18 |
$1K |
| 86900 |
|
318 |
304 |
$963.84 |
| 82728 |
|
75 |
71 |
$922.56 |
| 36416 |
|
612 |
486 |
$894.80 |
| 85018 |
|
407 |
389 |
$870.40 |
| 82550 |
|
199 |
177 |
$857.35 |
| 96376 |
|
122 |
39 |
$844.65 |
| 87634 |
|
12 |
12 |
$844.50 |
| 82962 |
|
361 |
263 |
$816.41 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
66 |
49 |
$769.36 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
106 |
97 |
$729.51 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
16 |
16 |
$640.50 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
14 |
14 |
$618.00 |
| 83550 |
|
73 |
72 |
$595.88 |
| 87428 |
|
32 |
29 |
$538.47 |
| 84100 |
|
189 |
167 |
$494.24 |
| 73610 |
|
12 |
12 |
$430.76 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
530 |
485 |
$424.54 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,765 |
2,565 |
$353.84 |
| 83540 |
|
72 |
71 |
$347.60 |
| 86695 |
|
35 |
28 |
$343.72 |
| 73560 |
|
12 |
12 |
$332.64 |
| 86592 |
|
52 |
51 |
$304.25 |
| 76775 |
|
13 |
12 |
$293.96 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
101 |
87 |
$290.67 |
| 73564 |
|
17 |
12 |
$271.24 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
94 |
89 |
$250.60 |
| J2704 |
Injection, propofol, 10 mg |
3,835 |
2,986 |
$199.51 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
68 |
61 |
$189.46 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
223 |
199 |
$183.74 |
| 82150 |
|
34 |
30 |
$148.59 |
| 84134 |
|
32 |
24 |
$143.29 |
| 82552 |
|
15 |
14 |
$120.77 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
87 |
67 |
$116.83 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,722 |
1,304 |
$115.40 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
110 |
92 |
$109.67 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
62 |
51 |
$90.74 |
| 82310 |
|
60 |
49 |
$72.64 |
| 81000 |
|
37 |
31 |
$72.03 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
879 |
760 |
$57.62 |
| 85652 |
|
33 |
25 |
$56.82 |
| 85045 |
|
12 |
12 |
$53.84 |
| J3490 |
Unclassified drugs |
15 |
13 |
$52.44 |
| J7510 |
Prednisolone oral, per 5 mg |
442 |
347 |
$50.62 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
18 |
13 |
$45.86 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
89 |
77 |
$44.63 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
877 |
759 |
$26.32 |
| J2060 |
Injection, lorazepam, 2 mg |
14 |
12 |
$25.99 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
50 |
43 |
$25.92 |
| 85730 |
|
37 |
37 |
$24.10 |
| 85610 |
|
50 |
49 |
$21.49 |
| 91301 |
|
305 |
214 |
$1.60 |
| A9270 |
Non-covered item or service |
883 |
729 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
40 |
29 |
$0.00 |
| 73502 |
|
12 |
12 |
$0.00 |
| 91300 |
|
81 |
78 |
$0.00 |
| 87631 |
|
68 |
53 |
$0.00 |
| 85014 |
|
38 |
38 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
20 |
12 |
$0.00 |